US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist

2.5000
+0.0400+1.63%

Trading Nov 26 10:55 ET

54.16MMarket Cap-868P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

207.08%6.07M

334.57%9.04M

80.62%7.21M

-44.49%15.35M

55.26%7.3M

-69.50%1.98M

-74.13%2.08M

-52.63%3.99M

3.92%27.65M

-31.00%4.7M

Selling and administrative expenses

20.15%2.35M

179.87%5.3M

71.73%3.74M

17.32%11.36M

131.64%5.33M

-12.84%1.96M

-27.42%1.89M

-13.81%2.18M

0.86%9.68M

2.04%2.3M

-General and administrative expense

20.15%2.35M

179.87%5.3M

71.73%3.74M

17.32%11.36M

131.64%5.33M

-12.84%1.96M

-27.42%1.89M

-13.81%2.18M

0.86%9.68M

2.04%2.3M

Research and development costs

16,818.18%3.72M

1,900.53%3.74M

91.33%3.46M

-77.79%3.99M

-17.90%1.97M

-99.48%22K

-96.56%187K

-69.29%1.81M

5.64%17.97M

-47.34%2.4M

Operating profit

-207.08%-6.07M

-334.57%-9.04M

-80.62%-7.21M

44.49%-15.35M

-55.26%-7.3M

69.50%-1.98M

74.13%-2.08M

52.63%-3.99M

-3.92%-27.65M

31.00%-4.7M

Net non-operating interest income expense

400K

Non-operating interest income

----

--400K

----

Other net income (expense)

49.33%224K

-66.89%97K

111.65%92K

-328.93%-728K

-213.39%-381K

3,650.00%150K

293K

-3,490.91%-790K

-27.89%318K

373.24%336K

Gain on sale of security

----

--200K

----

Special income (charges)

--0

---928K

--12K

---6K

--88K

---1.02M

--0

-Less：Restructuring and merger&acquisition

--0

--928K

---12K

--6K

---88K

--1.02M

--0

Other non- operating income (expenses)

43.59%224K

-52.68%97K

-60.34%92K

----

3,800.00%156K

--205K

1,154.55%232K

-27.89%318K

373.24%336K

Income before tax

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

Income tax

Net income

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

Net income continuous Operations

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

Minority interest income

Net income attributable to the parent company

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

42.43%-15.73M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

42.43%-15.73M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

Basic earnings per share

32.50%-0.27

-15.38%-0.45

18.10%-0.86

43.19%-3.42

-57.00%-1.57

71.43%-0.4

77.84%-0.39

43.55%-1.05

-2.21%-6.02

32.89%-1

Diluted earnings per share

32.50%-0.27

-15.38%-0.45

18.10%-0.86

43.19%-3.42

-57.00%-1.57

71.43%-0.4

77.84%-0.39

43.55%-1.05

-2.21%-6.02

32.89%-1

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	207.08%6.07M	334.57%9.04M	80.62%7.21M	-44.49%15.35M	55.26%7.3M	-69.50%1.98M	-74.13%2.08M	-52.63%3.99M	3.92%27.65M	-31.00%4.7M
Selling and administrative expenses	20.15%2.35M	179.87%5.3M	71.73%3.74M	17.32%11.36M	131.64%5.33M	-12.84%1.96M	-27.42%1.89M	-13.81%2.18M	0.86%9.68M	2.04%2.3M
-General and administrative expense	20.15%2.35M	179.87%5.3M	71.73%3.74M	17.32%11.36M	131.64%5.33M	-12.84%1.96M	-27.42%1.89M	-13.81%2.18M	0.86%9.68M	2.04%2.3M
Research and development costs	16,818.18%3.72M	1,900.53%3.74M	91.33%3.46M	-77.79%3.99M	-17.90%1.97M	-99.48%22K	-96.56%187K	-69.29%1.81M	5.64%17.97M	-47.34%2.4M
Operating profit	-207.08%-6.07M	-334.57%-9.04M	-80.62%-7.21M	44.49%-15.35M	-55.26%-7.3M	69.50%-1.98M	74.13%-2.08M	52.63%-3.99M	-3.92%-27.65M	31.00%-4.7M
Net non-operating interest income expense				400K
Non-operating interest income	----	----	----	--400K	----	----	----	----	----	----
Other net income (expense)	49.33%224K	-66.89%97K	111.65%92K	-328.93%-728K	-213.39%-381K	3,650.00%150K	293K	-3,490.91%-790K	-27.89%318K	373.24%336K
Gain on sale of security	----	----	----	--200K	----	----	----	----	----	----
Special income (charges)	--0	--0	--0	---928K	--12K	---6K	--88K	---1.02M	--0	--0
-Less：Restructuring and merger&acquisition	--0	--0	--0	--928K	---12K	--6K	---88K	--1.02M	--0	--0
Other non- operating income (expenses)	43.59%224K	-52.68%97K	-60.34%92K	----	----	3,800.00%156K	--205K	1,154.55%232K	-27.89%318K	373.24%336K
Income before tax	-220.03%-5.85M	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M
Income tax
Net income	-220.03%-5.85M	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M
Net income continuous Operations	-220.03%-5.85M	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M
Minority interest income
Net income attributable to the parent company	-220.03%-5.85M	-400.39%-8.94M	-48.84%-7.11M	42.43%-15.73M	-61.40%-7.34M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-220.03%-5.85M	-400.39%-8.94M	-48.84%-7.11M	42.43%-15.73M	-61.40%-7.34M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M
Basic earnings per share	32.50%-0.27	-15.38%-0.45	18.10%-0.86	43.19%-3.42	-57.00%-1.57	71.43%-0.4	77.84%-0.39	43.55%-1.05	-2.21%-6.02	32.89%-1
Diluted earnings per share	32.50%-0.27	-15.38%-0.45	18.10%-0.86	43.19%-3.42	-57.00%-1.57	71.43%-0.4	77.84%-0.39	43.55%-1.05	-2.21%-6.02	32.89%-1
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data